To identify the genes and pathways that confer resistance to frontline cancer therapies, researchers performed a genome-wide screen in haploid human ESCs.
[Cell Proliferation]
Home Newsletters ESC & iPSC News Genome-Wide Screen for Anticancer Drug Resistance in Haploid Human Embryonic Stem Cells
